Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.
Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Metz M, Tsianakas A, Pink A, Fage S, Micali G, Weisshaar E, Sundaram H, Metelitsa A, Augustin M, Wollenberg A, Homey B, Fargnoli MC, Sofen H, Korman NJ, Skov L, Chen X, Jabbar-Lopez ZK, Piketty C, Kwatra SG; OLYMPIA 1 Investigators. Ständer S, et al. Among authors: augustin m. JAMA Dermatol. 2024 Nov 27. doi: 10.1001/jamadermatol.2024.4796. Online ahead of print. JAMA Dermatol. 2024. PMID: 39602139
Continued treatment with baricitinib results in meaningful scalp responses among scalp non-responder patients with eyebrow/eyelash regrowth in the first year.
Mostaghimi A, Augustin M, Harada K, Senna M, Dutronc Y, Yu G, Ball S, Murage M, Kolodsick J, Brogan Y, King B. Mostaghimi A, et al. Among authors: augustin m. J Eur Acad Dermatol Venereol. 2024 Nov 21. doi: 10.1111/jdv.20334. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39569884 No abstract available.
Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies.
Simpson EL, Augustin M, Thaçi D, Misery L, Armstrong AW, Blauvelt A, Papp KA, Szepietowski JC, Boguniewicz M, Kwatra SG, Kallender H, Sturm D, Ren H, Kircik L. Simpson EL, et al. Among authors: augustin m. Am J Clin Dermatol. 2024 Nov 15. doi: 10.1007/s40257-024-00901-z. Online ahead of print. Am J Clin Dermatol. 2024. PMID: 39546129
Evaluation of skin cancer screening in Germany - a Microsimulation.
Baltus H, Hübner J, Garbe C, Hagenström K, Rohr M, Hischke S, Augustin J, Augustin M, Katalinic A, Eisemann N. Baltus H, et al. Among authors: augustin m. J Dtsch Dermatol Ges. 2024 Nov 9. doi: 10.1111/ddg.15539. Online ahead of print. J Dtsch Dermatol Ges. 2024. PMID: 39520317
From Gut to Blood: Redistribution of Zonulin in People Living with HIV.
Augustin M, Horn C, Ercanoglu MS, Bondet V, de Silva US, Suarez I, Chon SH, Nierhoff D, Zoufaly A, Wenisch C, Knops E, Heger E, Klein F, Duffy D, Müller-Trutwin M, Lehmann C. Augustin M, et al. Biomedicines. 2024 Oct 11;12(10):2316. doi: 10.3390/biomedicines12102316. Biomedicines. 2024. PMID: 39457626 Free PMC article.
Assessment and Monitoring of the Wound Micro-Environment in Chronic Wounds Using Standardized Wound Swabbing for Individualized Diagnostics and Targeted Interventions.
Rembe JD, Garabet W, Lackmann JW, Alizadehrahrouei S, Augustin M, Dissemond J, Ibing W, Köhrer K, Pfeffer K, Rommerskirchen A, Scharf SA, Wienemann T, Wachtmeister T, Schelzig H, Stuermer EK. Rembe JD, et al. Among authors: augustin m. Biomedicines. 2024 Sep 26;12(10):2187. doi: 10.3390/biomedicines12102187. Biomedicines. 2024. PMID: 39457500 Free PMC article.
1,221 results